Study of Transcranial Direct Current Stimulation to Treat Epilepsy
Focal Epilepsy
About this trial
This is an interventional treatment trial for Focal Epilepsy
Eligibility Criteria
Inclusion Criteria Clinical diagnosis of focal epilepsy. Estimated to have at least 2 countable seizures per month. Has not had control with at least 2 anti-seizure medicines. Able to maintain a constant medication for duration of the study (rescue meds allowed). Subject or legally authorized representative is able to understand consent and keep a seizure diary in English. Exclusion Criteria: A disease likely to progress over course of the study. Psychogenic non-epileptic seizures. Suicide attempt or psychiatric hospitalization past 2 years. A skin condition interfering with scalp electrodes or allergy to silver. Women will verify not pregnant, and if applicable, have a serum pregnancy test.
Sites / Locations
- Mayo Clinic MinnesotaRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
tDCS Treatment A (Low Amplitude)
tDCS Treatment B (High Amplitude)
Subjects with focal epilepsy that is not well-controlled on anti-seizure medications will receive 2 different treatments periods, each lasting 2 months, of transcranial direct current stimulation (tDCS). The initial treatment stimulation will be completed during the first 2-months.
Subjects with focal epilepsy that is not well-controlled on anti-seizure medications will receive 2 different treatments periods, each lasting 2 months, of transcranial direct current stimulation (tDCS). The last treatment stimulation will be completed during the following 2-months.